Merceditas Villanueva

Associate Professor of Medicine

Yale University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Merceditas Villanueva is an Associate Professor of Medicine at Yale University in the United States. Her research primarily focuses on HIV and Hepatitis C coinfection, addressing challenges in care and treatment engagement. Dr. Villanueva has investigated various aspects of HCV clearance, care cascades, and barriers within clinical environments, contributing valuable insights to improve health outcomes for affected populations.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (1)

Michael Virata

Associate Professor of Clinical Internal Medicine

Yale University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Merceditas Villanueva

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Hepatitis C Virus (HCV) Clearance Cascade for Persons With Human Immunodeficiency Virus (HIV)/HCV Coinfection Using Health Department Surveillance Data Among 7 US Jurisdictions Highlights the Role of HIV Care Engagement

Lemierre syndrome with pulmonary empyema caused byPrevotella intermedia

Challenges to Achieving HCV Micro-Elimination in People With HIV in the United States: Provider Perspectives and the Role of Implicit Bias

Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels

Creating a Longitudinal HCV Care Cascade for Persons With HIV/HCV Coinfection in Selected HIV Clinics Using Data to Care Methods

Expanded or Risk Factor-Based Annual Screening for Hepatitis C Virus (HCV) Among Persons With HIV: Which Is the Best Approach?

Future Directions for HIV/HCV Care: Lessons Learned From Local Evaluation Projects in Texas and Connecticut and Implications for Practice and Health Promotion

Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches

Provider-Created Mobile Application for Hepatitis C Care: Understanding Users’ Engagement for Training to Advance Hepatitis C Care (Preprint)

Advancing data to care strategies for persons with HIV using an innovative reconciliation process

Rapidly enlarging pulmonary mass due to immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent host with pulmonaryCryptococcus neoformans

Cumulative burden of non-communicable diseases predicts COVID hospitalization among people with HIV: A one-year retrospective cohort study

Collaborators (1)

Michael Virata

Make your next move.